[1]CurrentPatentAssignee:VTVTHERAPEUTICSNDGESDSTAATESDELAW-WO2007/3581,2007,A1Locationinpatent:Page/Pagecolumn75
849062-12-0
1072951-84-8
871125-81-4
849062-02-8
2121512-33-0
2828439-70-7
88271-29-8 | 2-(D-Gluco-pentylhydroxypentyl)-4(r)-1,3-thiazolidine-4-carboxylic acid | AA00GTJK | MFCD00186587
915925-42-7 | (5-Cyclobutyl-1,2,4-oxadiazol-3-yl)methanol | AA00GTNF | MFCD08691638
897019-55-5 | 3-Propoxy-azetidine, HCl | AA00GTQV | MFCD06804557
866545-96-2 | 1-(5-Bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)ethanone | AA00GU0G | MFCD12403936
926259-99-6 | N-(2-Aminophenyl)pyrazine-2-carboxamide | AA00GU5B | MFCD09046162
868238-05-5 | Methyl 2-(6-oxo-2-thioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetate | AA00GU96 | MFCD07343862
90916-46-4 | (4-Methyl-thiazol-2-yl)-phenyl-amine | AA00GUCH | MFCD00226635
865853-43-6 | (2S,3S,5S)-5-(acetoxymethyl)-tetrahydrofuran-2,3-diyl diacetate | AA00GUIE | MFCD16294559
883546-00-7 | 4-(PERFLUOROCYCLOHEXYL)BUTAN-1-OL | AA00GURF | MFCD06248652
876310-60-0 | 2-ADAMANTANECARBONYL-ARG-PHE-NH2 TRIFLUOROACETATE | AA00GV10 | MFCD11974995